Abbott LaboratoriesvsInMode

ABT and INMD stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$104.71

Value $182B

-2.55%
ABT's page

INMD

InMode Ltd.

$12.92

Value $819M

-1.75%
INMD's page

Abbott Laboratories (ABT) has a market value of $182B and InMode (INMD) $819M. Over the last year, with dividends, ABT moved -17.8% and INMD -8.8%. The P/E is 38.7 for ABT and 8.7 for INMD. Dividend yield: ABT 2.41%, INMD none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$182B

    INMD$819M

    ABT is 222 times INMD

  • Revenue, 12 months

    ABT$48.2B

    INMD$370M

    ABT is 130 times INMD

  • Net income, 12 months

    ABT$4.7B

    INMD$94M

    ABT is 50 times INMD

  • Operating margin

    ABT13.8%

    INMD23.1%

    9.3 points apart

  • ROIC

    ABT6.3%

    INMD9.9%

    3.6 points apart

  • P/E

    ABT38.7

    INMD8.7

    ABT is 4.4 times INMD

  • Dividend yield

    ABT2.4%

    INMD0.0%

    2.4 points apart

  • 5-year return

    ABT-11.6%

    INMD-86.4%

    74.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-11.6%

INMD-86.4%

5010020222023202420252026
Returns by period
PeriodABTWith dividendsINMDWith dividends
1 year since November 14, 2025-17.8%Price -19.8%-8.8%Price -8.8%
3 years since November 17, 2023+12.0%+3.9% a yearPrice +5.2%-41.5%-16.4% a yearPrice -41.5%
5 years since November 16, 2021-11.6%-2.4% a yearPrice -20.0%-86.4%-32.9% a yearPrice -86.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesINMDInMode

Valuation

ABTINMD
Valuation
Price$104.71$12.92
Market value$182B$819M
Enterprise value (EV)$209B$432M
P/E38.78.7
P/E, 5-year median33.710.3
P/B3.61.2
EV/EBIT31.45.1
Free cash flow yield3.7%10.3%

Results and growth

ABTINMD
Results and growth
Revenue, 12 months$48.2B$370M
Net income, 12 months$4.7B$94M
Free cash flow, 12 months$6.8B$84M
Earnings per share, 12 months$2.69$1.43
Revenue growth, year on year5.7%-6.2%
Revenue growth a year, past+5.1%over 5 years+12.4%over 5 years
EPS growth a year, past+8.3%over 5 years+10.0%over 5 years

Margins and returns on capital

ABTINMD
Margins and returns on capital
Gross margin56.9%78.5%
Operating margin13.8%23.1%
Net margin9.8%25.3%
ROIC6.3%9.9%
ROE9.1%13.7%

Balance sheet

ABTINMD
Balance sheet
Cash$4.3B$386M
Total debt$31.2B$8.2M
Net debt / EBITDA3.3-4.5
Interest cover6.7×–

Dividends and buybacks

ABTINMD
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$2.52–
Dividend growth a year, past+10.4%over 5 years–
Buyback yield0.5%15.6%
Shareholder yield2.9%15.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or INMD

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or InMode?

By market value, Abbott Laboratories ($182B) is about 222.3 times InMode ($819M), at today's prices.

How did ABT and INMD stock do over the last 5 years?

Since November 16, 2021, ABT's price moved -20.0% and INMD's -86.4%. With dividends: ABT -11.6% (-2.4% a year), INMD -86.4% (-32.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or INMD?

The dividend yield at today's price is 2.41% for Abbott Laboratories and none for InMode. Over the last twelve months they paid $2.52 and – per share.

What is the P/E of ABT and INMD?

At today's price, the P/E is 38.7 for ABT and 8.7 for INMD. The median of the last five years was 33.7 and 10.3, which shows where each stands against its own past.

Which has the higher profit margins, Abbott Laboratories or InMode?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and 25.3% for InMode, and the operating margin 13.8% and 23.1%. Revenue was $48.2B and $370M.

Which is the better investment, Abbott Laboratories or InMode?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.